Skip to main content
Premium Trial:

Request an Annual Quote

Dutch Medical Center to Use Oracle's Infrastructure for Personalized Medicine Research


NEW YORK (GenomeWeb) – Oracle said this week that Erasmus University Medical Center Rotterdam has selected the Oracle Health Sciences Translational Research Center and the Oracle Exadata Database Machine to support research projects focused on personalized medicine and better patient outcomes.

Erasmus chose its solution because of its ability to simultaneously query clinical and omics data, which "will be vital to advancing our next-generational genomics research initiatives," Jan Hazelzet, Erasmus' chief medical information officer, said in a statement. "As we expand the deployment across our enterprise, the platform's centralized data warehouse will enable in-depth analysis of patient outcomes and cost of care from a single source."

Oracle said that Erasmus will use the solution to analyze clinical and omics data to identify new biomarkers that could help clinicians make more personalized treatment recommendations. Erasmus' first project on the Oracle platform will focus on improving care and outcomes for patients with craniofacial malformations. The initiative will involve performing whole genome sequencing on over 1,000 patients, according to Oracle. Erasmus will also use the platform to explore the cost-effectiveness of specific treatments.

Financial and other terms of the agreement were not disclosed.

The Scan

Booster Push

New data shows a decline in SARS-CoV-2 vaccine efficacy over time, which the New York Times says Pfizer is using to argue its case for a booster, even as the lower efficacy remains high.

With Help from Mr. Fluffington, PurrhD

Cats could make good study animals for genetic research, the University of Missouri's Leslie Lyons tells the Atlantic.

Man Charged With Threatening to Harm Fauci, Collins

The Hill reports that Thomas Patrick Connally, Jr., was charged with making threats against federal officials.

Nature Papers Present Approach to Find Natural Products, Method to ID Cancer Driver Mutations, More

In Nature this week: combination of cryogenic electron microscopy with genome mining helps uncover natural products, driver mutations in cancer, and more.